With the accepted understanding of volume loss as one of the main factors in facial aging, oculofacial surgeons are embracing the concept of 'removing' less and 'filling' more. The purpose of this review is to present an update of the different alternatives and techniques for lower eyelid and midface restoration/ rejuvenation using filler agents.
INTRODUCTION
Over the past 20 years, surgeons have given particular attention to the aging process of the midface. Several approaches to midface rejuvenation have been discussed, the majority of which require complex surgical techniques.
Midface lifting [1] , lower eyelid fat repositioning [2] [3] [4] , and midface implants [5] [6] [7] are volume replacement procedures with a common goal: to create a youthful, lower eyelid-cheek contour. In a growing younger patient population, concern about early periocular aging changes has led to a general preference towards less invasive treatments. This cohort of young patients may lack the indications for more invasive or aggressive procedures.
This review discusses the published experience of several injectors in the treatment of the midface subunits with different filler agents. The work will describe and illustrate, through pictures and videos, preferred techniques and product selection according to the area to be treated. At the end of each section, a brief description of the more common adverse events and potential serious complications will be detailed along with recommendations on how to avoid or minimize such adverse events.
METHODS
The emphasis of this review is on literature published in the past 12-24 months, but includes more in-depth research into over 20 years' evolution of techniques and concepts on approaching involutional changes of the midfacial zone. Studies were identified by searching the PubMed database, without language restriction.
TEAR TROUGH DEFORMITY/NASOJUGAL GROOVE
A successful treatment of the tear trough requires a clear understanding of the cause of this deformity by the physician and the patient.
Definition
Flowers [8] and Loeb [4] are responsible for the descriptive names given to the concavity, which separates the lower eyelid from the cheek at the medial aspect of the inferior orbit. The tear trough is composed of thin skin adherent to the orbicularis muscle that is attached to the orbital rim. In the young patient, it is located in the medial third of the orbital rim and in more advanced ages, extends laterally up to the lateral canthus (Fig. 1) .
Patient selection
The 'ideal patient' to fill is the young patient (30-40 years old) with good skin tone and mildto-moderate concavity. The less than 'ideal patient' to fill is a patient with moderate to severe orbital fat herniation and significant skin laxity or skin tone (Fig. 2) ; these patients will clearly benefit from surgery.
Filler material
The preferred injectable implants for isolated teartrough deformity treatment are hyaluronic acid products. These materials are relatively simple to inject, have a good safety profile, and high patient tolerability and satisfaction. Another advantage of the hyaluronic acid products is that they can be dissolved away with hyaluronidase.
Autologous fat injection (lipofilling) by a highly experienced surgeon is a good filler option, but it is indicated and performed in patients with significant facial volume loss and in conjunction with surgery. Typically 5-7 cm 3 of fat graft is used to address each hemiface. Of the total fat graft injected, on average, approximately 32% of the volume injected remains after 16 months [9] . Overcorrection with lipofilling is advocated, based on subjective experience with reabsorption over time [10] . Some limitations of fat injections are the risks of lumpiness, long lasting irregularities and prolonged edema. Due to its particulate consistency, the procedure also carries a theoretical higher potential of intravascular embolization.
Other fillers, such as calcium hydroxylapatite and poly-L-lactic acid, which are considered semipermanent fillers (effect lasting 12-24 months), are widely used for midface volume restoration, but their application for tear-trough correction has been discouraged because of lack of precision and increased risk of complications in this unforgiving area.
KEY POINTS
Our recent understanding of the aging process supports the concept of volume restoration as a key step for facial rejuvenation.
Filler materials are different in their physicochemical properties giving them the ability to provide better support or lifting capability depending on the treated facial zone.
Successful volumetric correction of the lower lid/ midface region depends on proper patient selection, precise and consistent injection technique and choosing the appropriate filler material combination. 
Preparation and anesthesia
Precise product placement requires meticulous patient preparation.
Preparation First, the patient is seated at an angle of approximately 908 or the patient is asked to look up; either method will accentuate the deformity. Once the patient is in the correct position, proceed to mark the tear trough and adjacent areas. Marking the tear trough and adjacent areas is beneficial for patient orientation, for injection planning and for photographic documentation (Fig. 3) . However, most injectors do not mark in this area.
Anesthesia
Topical anesthesia is applied after preparing the skin. Local blocks are not necessary in the majority of cases, but some injectors favor the use of local vasoconstrictive anesthesia at the injection site [16] to reduce the chance of hematoma formation. However, local injectable anesthetic, antibiotic and antiviral prophylaxes are not routinely used.
Procedure
As in most cosmetic procedures there are several injection techniques. A beginner injector should probably adopt the technique with the lowest incidence of complications.
Techniques
The injection technique is widely discussed in the literature reviewed [12
&& , [16] [17] [18] and is summarized in http://youtu.be/2zEXWQvgRfM. Filler is placed at the preperiosteal plane below orbicularis muscle. This is the deep rim technique and is the most widely used technique because it is well tolerated and easy to perform (Fig. 4) .
One highly experienced injector, Kane [19] , favors superficial plane injections at the dermal/ orbicularis muscle interface. His arguments in favor of such a superficial placement of filler are better correction and a lower rate of ecchymosis. He also cites a more efficient use of the filling material resulting in the use of less material for correction. Nevertheless, use of this technique should be reserved only to those physicians with vast experience in the treatment of infraorbital hollows.
Injection of filler: needle versus cannula
Most injectors use a standard 30 or 32 gauge needle [19, 20] , but the product comes with a prepacked 27 gauge needle. Berros [14 && ] has described his technique of periorbital and tear-trough treatment using a specially designed cannula for periorbital use. In his article, he reports a lower incidence of hematoma formation (13%) and lid edema (21%) as compared with Goldberg's series [20] , which reported an incidence of 27% for bruising and 15% for edema using the standard needle technique.
Preference of cannula over needle seems to be favored by those with experience in autologous fat implantation. However, further studies are needed to support the reported lower incidence of hematoma/bruising formation with cannula technique versus needle injections.
Product choice
There are several options of fillers. Of the commercially available Federal Drug Administration approved hyaluronic acid fillers, Restylane and Juvéderm are probably the most widely injected materials because their high safety profile.
Some injectors prefer Restylane over Juvéderm claiming that the more hydrophilic quality of the latter results in prolonged edema around the eyes, whereas other injectors favor the use of Juvéderm over Restylane, arguing that the latter is more granular making it more prone to exhibit the Tyndall effect (bluish discoloration) in some patients [11 && ].
Restylane has a higher viscosity and elasticity than Juvérderm [21, 22, 23 && ], meaning that it has more lifting and support capability [22] with a lower possibility of product migration. It will feel firmer after injection. Juvéderm, with low viscosity and elasticity, will tend to spread into the tissue and have a softer feel. This may explain why Juvéderm is probably preferred over Restylane for lip augmentation. In summary, the preference of either product for tear-trough correction depends on the specific characteristics of the patient and the injector experience with each filler agent.
Complications
Bruising and hematoma formation are the most common complications of infraorbital hollow filler injection.
Ecchymosis or bruising
Goldberg reported a 27% incidence [20] of bruising in his series. The chance of bleeding increases with the number of passes through the orbicularis muscle. To avoid this complication, injections should be made with the smallest caliber needle, 30-32 gauge, using a one-inch needle instead of the prepacked 0.5-inch needle supplied. A longer needle will reach the whole extension of the groove without the need of doing several re-entry points through the orbicularis. Prior to the procedure, it is important to know if the patient is taking anticoagulants, such as aspirin or Coumadin, as this will increase the risk of bleeding and hematoma formation. After treatment, apply ice to the injected areas to decrease the possibility of postprocedure edema and bruising.
Edema/fluid build up Patients must be instructed regarding the hydrophilic nature of this filler and the possibility of experiencing swollen eyelids for 2-3 weeks after the procedure. Avoid injecting hyaluronic acid in patients with a strong tendency toward periorbital edema.
Visibility of material
Visible material associated with a gray or blue color, called the Tyndall effect, may be detected at the injection site. This is a refractive phenomenon produced by superficially placed material. To minimize occurrence of this phenomenon, filler must be injected deep into the tissue and in small amounts, usually from 0.2 to 0.5 ml per eyelid. Hyaluronidase should be available for correction of visible material, tissue irregularities or unresolved tissue edema.
Vision threatening complications
Kassir and Fierlbeck have reported that periorbital hyaluronic acid gel injections have a remote risk of distant embolization and local occlusive necrosis [24 && ,25] . Due to the cohesive quality of the product, this is considered a very rare complication. Nevertheless, the possibility of a sight-threatening event should be listed in all consent forms. A low-pressure injection in a discontinuous and retrograde manner, that is, slow product injection (0.3 ml/min or less) and syringe aspiration will further reduce the possibility of intravascular injection.
Hypersensitivity reactions
Hypersensitivity reactions to hyaluronic acid gel have a reported incidence of about 0.6% [26] . About 50% of reactions such as redness and abnormal swelling occur immediately whereas others may appear weeks or months after the treatment [27] . Although manufacturers do not recommend a skin test, patients must be aware of this possibility when they consent to treatment.
MALAR, INFRAMALAR, AND ZYGOMATIC AREA
For a beginner injector, the malar-zygomatic region may represent a more challenging area to achieve proper product placement. The treatment goal is to correct deficiencies in soft tissue or bone.
In a recent article, Cattin [28 && ] has described a novel single injection technique for midface rejuvenation using a blunt cannula. The injector advocates for the placement of product at the subdermal level and above the muscle using cross-linked hyaluronic acid, with or without lidocaine. The harder Juvéderm Voluma Gel (See Table 1 ) is used for greater lift on those patients with more volume deficit, whereas softer Juvéderm Ultra Plus is used for smaller corrections.
Product placement in a very specific anatomic location is achieved by using Hinderer's lines (Fig. 5) . The injection of the filler is directed from the superior border of the malar area to the more inferior, maxillary zone, which is a variation from previous midface injection techniques favoring injection direction placement from an inferior to superior location [29 && ].
Patient selection
Malar-zygomatic augmentation is a procedure likely more indicated for females. This procedure is used either to correct volume loss or to enhance facial features. In men, acquired or congenital maxillary/ malar deficiency may be a reasonable indication to treat. Again, the ideal patient should have adequate skin tone and minimal-to-moderate tissue laxity or sagging.
Filler material
Filler material selection determines depth of injection. Semi-permanent or higher viscosity fillers, such as Sculptra and Radiesse, are usually injected at the deeper planes in a supra-periosteal location whereas 'softer' or less viscous materials may be injected at the more superficial, sub-dermal location as described by Cattin [28 && ].
Techniques
Cattin's single injection technique may be a reasonable approach for the less experienced injector. It offers the advantage of specific product location and is relatively well tolerated in terms of more serious potential complications. However, both the injector and the patient should be aware of the possibility of periorbital edema following hyaluronic acid gel injections at the more superficial subcutaneous plane. http://youtu.be/o3fAKevxMSg shows the midface zone injection technique using Sculptra. Please note that at the malar prominence injections are deep, and direct injections into the more superficial malar fat pad are avoided.
Complications
Adverse events are the same as previously discussed for tear trough injection; ecchymosis, edema, material visibility or palpable irregularities. The placement of hyaluronic acid gels in the more superficial subcutaneous plane is described as a safer technique for the beginner injector but it has the potential complication of prolonged periorbital edema.
Unresolved periorbital edema was reported in one of four patients in a series published by Griepentrog and Lucarelli [30 && ]. The persistent fullness in some of those patients was successfully treated with hyaluronidase injection. Identification of signs or symptoms in patients who are prone to develop edema is difficult. A careful history of fluid retention, seasonal allergies, previous lower lid or midface surgery and presence of festoons on examination should warn the physician about this common potential complication after filler injection.
LATERAL/TEMPORAL CHEEK
Rohrich and Pessa [31] have proposed that the fat compartments of the face are partitioned into discrete units. These separate compartments or units age in a different chronological sequence, which explains why the smooth convexity or curves of the young face turn into a surface of 'hills' and 'valleys'. They have described the lateral temporal-cheek as the most lateral compartment of cheek fat, lying superficial to the parotid gland and connecting to temporal superior fat and cervical subcutaneous fat. http://youtu.be/3JF1Hq3CzKU demonstrates injection technique at the temporal fossae /lateral cheek facial zone. Treatment of this area requires a physician who is experienced and is able to perceive changes that usually go unnoticed to most patients. Fitzgerald and Vleggaar's article on volume restoration with poly-L-lactic acid [29 && ] is an excellent guide to complete facial volumization.
CONCLUSION
Nonsurgical approaches for facial rejuvenation are in continuous demand by patients. Practitioners should be aware of the differences between filler materials as the specific physicochemical or rheological properties of each may determine if a product will perform efficiently in a specific anatomic location.
Good patient selection, usually the young to middle aged patient (30-50 years old) with adequate skin tone, and meticulous injection technique are probably the most important factors for a successful outcome. As of yet, we do not have an 'ideal filler', but in order to better comply with patients' expectations of achieving a natural, long lasting, cosmetic result, a combination of soft lower viscosity products and harder higher viscosity fillers should be considered.
